Navigation Links
TPI Attends 23rd ROTH Annual OC Growth Stock Conference from March 13-16, 2011
Date:3/11/2011

CHENGDU, China, March 11, 2011 /PRNewswire-Asia-FirstCall/ --Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals is invited to present at the 23rd ROTH Annual OC Growth Stock Conference from March 13 - 16, 2011 at the Ritz Carlton in Dana Point, California.

Dr. James Jiayuan Tong, Chief Financial Officer, Chief Business & Development Officer and Board Director of the Company will present at 8:30 am, March 16, at track 2 of the Conference.

An updated Company's presentation can be found on the Investors Relations of www.tianyinpharma.com

About TPITPI, headquartered at Chengdu, China, is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical medicine, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. TPI currently manufactures a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

More information regarding the Company can be found at: http://www.tianyinpharma.com.

Safe Harbor StatementThe Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.For more information, please contact:James Jiayuan Tong M.D. Ph.D.Chief Financial Officer, Chief Business & Development OfficerDirectorTianyin Pharmaceutical Co., Inc.Web:
http://www.tianyinpharma.comEmail:   Dr.Tong@tianyinpharma.comTel:
+86-28-8551-6696 (Chengdu, China)+86-134-3655-0011 (China)+1-949-350-6999 (U.S.)Address: 23rd Floor Unionsun Yangkuo PlazaNo 2 Block 3 South Renmin RoadChengdu, 610041China
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Curemark Attends North American Bio Forum at Canadian Government Invitation
2. US Oncology Clinical Development Attends Partnerships With CROs
3. Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
4. UBM Announces Content for 10th Annual Japanese Pharma & Bio Events
5. 6th Annual Szent-Gyorgyi Prize for Progress in Cancer Research Awarded to Beatrice Mintz, Ph.D.
6. Talecris Biotherapeutics Announces Record Date for 2011 Annual Meeting of Shareholders
7. NeoStem to Present at Cowen Group 31st Annual Health Care Conference on March 7 and 8
8. BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
9. Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
10. Huifeng Bio-Pharmaceutical Technology, Inc. to Present at the 2011 Rodman & Renshaw Annual China Investment Conference in Shanghai
11. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 Patients are the most ... CSL Behring awards Local Empowerment for Advocacy Development (LEAD) ... groups. These groups tackle complex legislative and public policy ... Hill and in statehouses across the U.S. ... was awarded to New England Hemophilia Association (NEHA), Neuropathy ...
(Date:3/29/2017)... COLORADO SPRINGS, CO , March 29, 2017 /PRNewswire/ - Last year,s ... who support kratom are not the only efforts active to generate ... that substitute opiate based pharmaceutical drugs in the healthcare market place. ... Earlier this ... U.S. based developer and distributor of pharmaceutical and nutritional products, announced ...
(Date:3/29/2017)... ... March 29, 2017 , ... ComplianceOnline, the leading governance, ... announced its 3rd Annual Medical Device Summit 2017 venue and speaker lineup. The Summit ... Hotel, in Boston, MA. , The Omni Parker House Hotel, which is located at ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... cell-based assays, disperses a quarterly travel award to noteworthy scientists who will be ... announced that its new round of awards are being given to two postdoctoral ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
Breaking Biology News(10 mins):